BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It is one of the most widely studied peptides in regenerative research, valued for its stability and its role in tissue-repair signaling models. Every VITRA batch is synthesized under ISO-class cleanroom conditions and released only after full analytical confirmation.

In published research models, BPC-157 is associated with the modulation of growth-factor pathways (notably VEGF and the nitric-oxide system), promotion of angiogenesis, and regulation of fibroblast migration. These signaling interactions are studied for their influence on angiogenic and cytoprotective repair processes at the cellular level.

• Tissue repair
• Cytoprotection
• In-vitro assays

Store lyophilized peptide at 2–8°C for short-term handling and at -20°C for long-term storage, protected from light and moisture. Once reconstituted, refrigerate at 2–8°C and use within the validated stability window. Avoid repeated freeze-thaw cycles.

Reconstitute with bacteriostatic or sterile water for research use. Add diluent slowly against the vial wall — do not inject directly onto the powder — and swirl gently until fully dissolved rather than shaking. Do not use if the solution appears cloudy or contains particulates.

• [01]Sikiric P. et al. Stable gastric pentadecapeptide BPC-157 in the therapy of gastrointestinal and other lesions. Curr Pharm Des.
• [02]Chang C.H. et al. The promoting effect of pentadecapeptide BPC-157 on tendon healing. J Appl Physiol.
• [03]Seiwerth S. et al. BPC-157 and blood vessels. Curr Pharm Des.